Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Publications

Selected Publications

2025

  • Al Hamwi, G., Alnouri, M. W., Verdonck, S., Leonczak, P., Chaki, S., Frischbutter, S., Kolkhir, P., Matthey, M., Kopp, C., & Bednarski, M. (2025). "Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease models." Signal transduction and targeted therapy, 10(1), 128. 
  • Altunergil, T., Pereira, M. P., Altrichter, S., Gutsche, A., Ahsan, D. M., Fox, L., Grekowitz, E., Bonnekoh, H., Weller, K., & Maurer, M. (2025). "Development and Validation of a Disease Severity Index for Patients With Cold Urticaria." The Journal of Allergy and Clinical Immunology: In Practice, 13(9), 2338-2348. e2339. 
  • Arasi, S., Pite, H., Beken, B., Alvaro‐Lozano, M., Brough, H., Caffarelli, C., Church, M. K., Flohr, C. C., Janmohamed, S. R., & Konstantinou, G. N. (2025). "An overview on current practices regarding the diagnosis and management of chronic urticaria in pediatrics: An EAACI Task Force report." Pediatric Allergy and Immunology, 36(8), e70174. 
  • Benezeder, T., Bordag, N., Woltsche, J., Teufelberger, A., Perchthaler, I., Weger, W., Salmhofer, W., Gruber-Wackernagel, A., Painsi, C., & Zhan, Q. (2025). "Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment." Journal of Dermatological Science. 
  • Bergmann, K.-C., Straff, W., Mücke, H.-G., Stevanovic, K., & Zuberbier, T. (2025). "Recommendations for allergy-friendly urban planting in the context of climate change." Allergo Journal International, 1-9. 
  • Bergmann, K. C., & Zuberbier, T. (2025). "Effect of the Multi‐Strain Probiotic SYN‐53 in the Management of Allergic Rhinoconjunctivitis." Allergy. 
  • Bernstein, J. A., Schatz, M., & Zuberbier, T. (2025). "In lasting tribute: Professor Marcus Maurer (1966-2024)—a visionary in allergy research and a highly respected physician." The Journal of Allergy and Clinical Immunology: In Practice, 13(3), 452-453. 
  • Betschel, S. D., Peter, J., Lumry, W., Longhurst, H., Katelaris, C. H., van Kooten, S., Heckmann, M., Malloy, N., Ulloa, J., & Danese, S. (2025). "Factors contributing to non-compliance with on-demand treatment guidelines in hereditary angioedema." Allergy, Asthma & Clinical Immunology, 21(1), 25. 
  • Bizjak, M., Aerts, O., Pesqué, D., Muñoz, M., Asero, R., Gonçalo, M., Rustemeyer, T., Košnik, M., Kačar, M., & Goossens, A. (2025). "Contact Urticaria and Related Conditions: Clinical Review." Contact dermatitis. 
  • Bonnekoh, H., Munoz, M., & Kolkhir, P. (2025). "A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain." JAMA, 333(8), 715-716. 
  • Bousquet, J., Sousa-Pinto, B., Canonica, G. W., Klimek, L., Samolinski, B., & Zuberbier, T. (2025). "The ARIA® guidelines and the EUFOREA non-evidence-based algorithm cannot be compared and embedded in an integrated approach." Current allergy and asthma reports, 25(1), 45. 
  • Buttgereit, T., Aulenbacher, F., Adatia, A., Ayala, C. V., Al-Nesf, M. A., Altrichter, S., Abuzakouk, M., Al-Ahmad, M., Ali, R. M., & Berardi, A. (2025). "Unmet needs in hereditary angioedema: an international survey of physicians." Orphanet Journal of Rare Diseases, 20(1), 383. 
  • Buttgereit, T., Gutsche, A., & Magerl, M. (2025). "Observations on quality of life and disease control in patients with hereditary angioedema." Skin health and disease, 5(5), 368-371. 
  • Casale, T. B., Gimenez-Arnau, A. M., Bernstein, J. A., Holden, M., Zuberbier, T., & Maurer, M. (2025). "A plain language summary of a review about omalizumab for people with chronic spontaneous urticaria." Immunotherapy, 17(4), 239-245. 
  • Castells, M., Akin, C., Hartmann, K., Broesby-Olsen, S., George, T. I., Powell, D., Bidollari, I., Lin, H.-M., Lampson, B., & Doyle, A. (2025). "Continued symptom and quality of life improvement with favorable safety shown with long-term avapritinib in indolent systemic mastocytosis." The Journal of Allergy and Clinical Immunology: In Practice. 
  • Cherrez-Ojeda, I., Faytong-Haro, M., Alvarez-Muñoz, P., Larco, J. I., de Arruda Chaves, E., Rojo, I., Moncayo, C. V., Ramon, G. D., Rodas-Valero, G., & Kocatürk, E. (2025). "How accurate are ChatGPT-4 responses in chronic urticaria? A critical analysis with information quality metrics." World Allergy Organization Journal, 18(7), 101071. 
  • Cohn, D. M., Gurugama, P., Magerl, M., Katelaris, C. H., Launay, D., Bouillet, L., Petersen, R. S., Lindsay, K., Aygören-Pürsün, E., & Maag, D. (2025). "CRISPR-based therapy for hereditary angioedema." New England Journal of Medicine, 392(5), 458-467. 
  • Cohn, D. M., Soteres, D. F., Craig, T. J., Lumry, W. R., Magerl, M., Riedl, M. A., Audhya, P. K., Maurer, M., & Bernstein, J. A. (2025). "Interplay between on-demand treatment trials for hereditary angioedema and treatment guidelines." Journal of Allergy and Clinical Immunology, 155(3), 726-739. 
  • Coscarella, G., Rosen, Y., Singer, N., Eyal, E., Haimson, L., Goren, O., Hagai, E., Edwards, E., Pereira, M. P., & Stander, S. (2025). "Diagnostic unmet needs in brachioradial pruritus." Journal of the American Academy of Dermatology. 
  • Deschildre, A., Alvaro‐Lozano, M., Muraro, A., Podesta, M., de Silva, D., Giovannini, M., Barni, S., Dribin, T. E., Sandoval‐Ruballos, M., & Anagnostou, A. (2025). "Towards a common approach for managing food allergy and serious allergic reactions (anaphylaxis) at school. GA2LEN and EFA consensus statement." Clinical and Translational Allergy, 15(1), e70013. 
  • Elieh-Ali-Komi, D., Maurer, M., & Siebenhaar, F. (2025). "The Impact of Mast Cells on the Anatomy, Cellular Communication, and Molecular Immune Network of Lymph Nodes." Clinical reviews in allergy & immunology, 68(1), 35. 
  • Elieh-Ali-Komi, D., Shafaghat, F., Alipoor, S. D., Kazemi, T., Atiakshin, D., Pyatilova, P., & Maurer, M. (2025). "Immunomodulatory significance of mast cell exosomes (MC-EXOs) in immune response coordination." Clinical reviews in allergy & immunology, 68(1), 20. 
  • Erdem, Y., Özkaya, E., Erbilgin, Y., Saritas, M., Sayitoglu, M., Su Küçük, Ö., Salman, A., Yucelten, A. D., Kocatürk, E., & Taskapan, O. (2025). "Filaggrin Gene Variants Among Patients With Atopic Dermatitis in Turkey: A Multicenter Study Investigating Its Relationship With Disease Severity and Clinical/Laboratory Findings." Dermatitis®. 
  • Ertaş, R., Yücel, M. B., Türk, M., Ketenci Ertaş, Ş., Kocatürk, E., & Muñoz, M. (2025). "Physical Exercise Improves Symptomatic Dermographism." Clinical and Translational Allergy, 15(7), e70083. 
  • Fomina, D. S., Lebedkina, M. S., Bobrikova, E. N., Yukhnovskaya, Y. D., Roppelt, A. A., Mukhina, O. A., Markina, U. A., Alexeeva, Y. G., Nikitina, E. A., & Maurer, M. (2025). "Recurrent angioedema manifestation and treatment response in two patients from different families caring the myoferlin gene mutation: case series." Orphanet Journal of Rare Diseases, 20(1), 424. 
  • Gau, S.-Y., Lo, S.-W., Hsu, C., Chen, S.-J., Zuberbier, T., & Chang, H.-C. (2025). "Human papillomavirus infection is associated with increased risk of new-onset hidradenitis suppurativa: A population-based cohort study." Journal of the American Academy of Dermatology, 92(3), 444-451. 
  • Gau, S.-Y., Lo, S.-W., Tu, Y.-F., Liao, W.-C., Su, Y.-J., Chang, H.-C., Zuberbier, T., Metz, M., & Chen, S.-J. (2025). "Human Papillomavirus Infection Increases Risk of New-Onset Prurigo Nodularis: A Multi-Center Retrospective Cohort Study Using Global and US Electronic Medical Records of TriNetX network." Journal of the American Academy of Dermatology. 
  • Gialama, D., Bonnekoh, H., Rothermel, N. D., Oldenburg, R., Khan, D. A., Hoffman, H. M., Lang, D., & Kolkhir, P. (2025). "Differential diagnosis of chronic spontaneous urticaria." The Journal of Allergy and Clinical Immunology: In Practice. 
  • Globig, P., Morakabati, P., Höfer, V., Willmes, D. M., Babina, M., & Worm, M. (2025). "Acetylsalicylic acid aggravates anaphylaxis in a PGE 2-dependent manner." The Journal of Clinical Investigation, 135(5). 
  • Grekowitz, E., Salameh, P., Altrichter, S., Ahsan, D. M., Weller, K., Metz, M., Pereira, M. P., & Terhorst-Molawi, D. (2025). "Validation of the Urticaria Activity Score for Cold Urticaria (ColdUAS)." The Journal of Allergy and Clinical Immunology: In Practice. 
  • Guilarte, M., Lumry, W. R., Magerl, M., Martinez Saguer, I., Reshef, A., Sobotkova, M., Braverman, J., Lawo, J.-P., Wieman, L., & Nenci, C. (2025). "Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema." Paper presented at the Allergy and Asthma Proceedings.
  • Gutsche, A., Salameh, P., Jahandideh, S. S., Roodsaz, M., Kutan, S., Salehzadeh‐Yazdi, A., Kocatürk, E., Gregoriou, S., Thomsen, S. F., & Kulthanan, K. (2025). "Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?" Clinical and translational allergy, 15(8), e70087. 
  • Hatic, E., Färdig, M., Amaral, A. F., Jarvis, D., Accordini, S., Bousquet, J., Garcia-Aymerich, J., Tan, W. C., Zuberbier, T., & Janson, C. (2025). "Evaluation of recently proposed thresholds to define spirometry bronchodilator response." ERJ open research, 11(3). 
  • Jiao, Q., Lohse, K., Rauber‐Ellinghaus, M. M., Kolkhir, P., Frischbutter, S., Scheffel, J., Xiang, Y. K., Maurer, M., & Altrichter, S. (2025). "Basophil and eosinophil recruitment to skin lesions is linked to features of autoimmune chronic spontaneous urticaria including basopenia." Journal of the European Academy of Dermatology & Venereology, 39(2). 
  • Kocatürk, E., Chu, D. K., Türk, M., Röckmann, H., Van Doorn, M., Nochaiwong, S., & Zuberbier, T. (2025). "Management of chronic spontaneous urticaria made practical: what every clinician should know." The Journal of Allergy and Clinical Immunology: In Practice. 
  • Kocatürk, E., & Zuberbier, T. (2025). "Navigating Non‐Response: Prognosis and Strategies in Chronic Spontaneous Urticaria Management." International Journal of Dermatology, 64(2), 227-228. 
  • Kolkhir, P., Bieber, K., Hawro, T., Kridin, K., Ludwig, M. A., Olbrich, H., Metz, M., Vorobyev, A., Ludwig, R. J., & Maurer, M. (2025). "Mortality in adult patients with chronic spontaneous urticaria: a real-world cohort study." Journal of Allergy and Clinical Immunology, 155(4), 1290-1298. 
  • Kolkhir, P., Fok, J. S., Kocatürk, E., Li, P. H., Okas, T.-L., Marcelino, J., & Metz, M. (2025). "Update on the Treatment of Chronic Spontaneous Urticaria." Drugs, 1-12. 
  • Lapiņa, L., Kaņepa, A., Zolovs, M., Buttgereit, T., & Kurjāne, N. (2025). "Adaptation and Linguistic Validation of Angioedema PROMs in Latvian for Assessing Recurrent Angioedema." Journal of Clinical Medicine, 14(4), 1375. 
  • Lebedkina, M., Kovalkova, E., Andrenova, G., Dushkin, A., Chernov, A., Nikitina, E., Karaulov, A., Lysenko, M., Maurer, M., & Kocatürk, E. (2025). "Chronic inducible urticaria–having more than one is common and clinically relevant." Frontiers in Immunology, 16, 1584771. 
  • Li, H. H., Aygören-Pürsün, E., Magerl, M., Craig, T. J., Manning, M. E., Hummel, N., Kopiec, A., Fu, S., Morris, J., & Wang, A. (2025). "Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks." Allergy, Asthma & Clinical Immunology, 21(1), 10. 
  • Li, Z., Schneikert, J., Bal, G., Jin, M., Franke, K., Zuberbier, T., & Babina, M. (2025). "Intrinsic Regulatory Mechanisms Protect Human Skin Mast Cells from Excessive MRGPRX2 Activation: Paucity in LAD2 (Laboratory of Allergic Diseases 2) Cells Contributes to Hyperresponsiveness of the Mast Cell Line." Journal of Investigative Dermatology, 145(5), 1215-1219. e1214. 
  • Li, Z., Schneikert, J., Bal, G., Zuberbier, T., & Babina, M. (2025). "Icatibant Acts as a Balanced Ligand of MRGPRX2 in Human Skin Mast Cells." Biomolecules, 15(9), 1224. 
  • Magerl, M., Bouillet, L., Martinez-Saguer, I., Gavini, F., Bent-Ennakhil, N., Sayegh, L., & Andresen, I. (2025). "Real-World Effectiveness of Lanadelumab in Hereditary Angioedema: Multicountry INTEGRATED Observational Study." The Journal of Allergy and Clinical Immunology: In Practice, 13(2), 378-387. e372. 
  • Magerl, M., Riedl, M. A., Arruda, L. K., Bauer, A., Berardi, A., Bernstein, J. A., Bouillet, L., Buckland, M., Buttgereit, T., & Cohn, D. M. (2025). "Global frequency, diagnosis, and treatment of hereditary angioedema with normal C1 inhibitor." The Journal of Allergy and Clinical Immunology: Global, 4(3), 100446. 
  • Maier, P., Macht, M., Beck, S., Kolkhir, P., Babina, M., Kremer, A. E., Zahn, D., & Wolf, K. (2025). "MRGPRX2 ligandome: Molecular simulations reveal three categories of ligand-receptor interactions." Journal of structural biology, 217(2), 108193. 
  • Maurer, M., Cimbollek, S., Kelly, M., Rodney, K., Elliott, J., LoboGuerrero, E., & Magerl, M. (2025). "Real-world evidence of the effectiveness and utilization of subcutaneous C1INH long-term prophylaxis in patients with HAE in Spain and Germany." Frontiers in Immunology, 16, 1576235. 
  • Muñoz, M., Schoepke, N., Altrichter, S., Staubach, P., Geppert‐Steidl, C., Durner, L., Bernstein, J. A., Maurer, M., & Weller, K. (2025). "Development of the symptomatic dermographism quality of life questionnaire." Clinical and Translational Allergy, 15(2), e70038. 
  • Neisinger, S., Kiefer, L., Salameh, P., Bonnekoh, H., Buttgereit, T., Gutsche, A., Herzog, L., Munoz, M., Pankow, A., & Maurer, M. (2025). "Addictive behavior is not a comorbidity of chronic spontaneous urticaria." Allergology International, 74(2), 325-326. 
  • Neisinger, S., Salameh, P., Gutsche, A., Aulenbacher, F., Siebenhaar, F., & Maurer, M. (2025). "Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients." Clinical and Translational Allergy, 15(1), e70026. 
  • Pereira, M. P., Stevanovic, K., Kocatürk, E., Meesch, C., van Hofman, I., Vaswani, P. S., Bernstein, J. A., Bruscky, D., Chong‐Neto, H. J., & Chu, C. Y. (2025). "International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives." JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 
  • Puxkandl, V., Aigner, S., Burner, T., Lackner, A., Moñino-Romero, S., Kimeswenger, S., Hoetzenecker, W., & Altrichter, S. (2025). "Rapid Change in FcεRI Occupancy on Basophils After Venom Immunotherapy Induction." International journal of molecular sciences, 26(15), 7511. 
  • Redhu, D., Kumari, V., Franke, K., Hartmann, K., Worm, M., & Babina, M. (2025). "TNF-α counters skin inflammation by restraining mast cell–dependent thymic stromal lymphopoietin production." Journal of Allergy and Clinical Immunology. 
  • Rothermel, N. D., Vera Ayala, C., Gonçalo, M., Fok, J. S., Herzog, L. S., Kocatürk, E., Neisinger, S., Pereira, M. P., Podder, I., & Pyatilova, P. (2025). "Managing urticarial vasculitis: a clinical decision-making algorithm based on expert consensus." American journal of clinical dermatology, 26(1), 61-75. 
  • Schnarkowski, P., Salameh, P., Grekowitz, E., Terhorst-Molawi, D., Maurer, M., Weller, K., & Altrichter, S. (2025). "Validation of the Cholinergic Urticaria Activity Score (CholUAS)." The Journal of Allergy and Clinical Immunology: In Practice, 13(1), 213-219. e213. 
  • Siebenhaar, F., Brehler, R., Christen, D., Hartmann, K., Altrichter, S., Joest, M., aufm Kampe, K., Lang, C. C., Lippert, U., & Mülleneisen, N. (2025). "Mastocytosis in the age of precision medicine." 
  • Siebenhaar, F., Sofi, S., Neisinger, S., Akin, C., Pyatilova, P., Grekowitz, E., Haendel, A., Hawro, T., Kiefer, L., & Magerl, M. (2025). "The Mastocytosis control test: a patient-reported outcome measure assessing disease control." The Journal of Allergy and Clinical Immunology: In Practice, 13(3), 647-657. e643. 
  • Soegiharto, R., Alizadeh Aghdam, M., Sørensen, J., van Lindonk, E., Bulut Demir, F., Mohammad Porras, N., Matsuo, Y., Kiefer, L., Knulst, A., & Maurer, M. (2025). "Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real‐world data from a large multi‐national UCARE study." Allergy, 80(2), 489-499. 
  • Soegiharto, R., Van der Wind, E., Alizadeh Aghdam, M., Sørensen, J. A., Van Lindonk, E., Bulut Demir, F., Mohammad Porras, N., Matsuo, Y., Kiefer, L., & Knulst, A. C. (2025). "Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study." Clinical & Experimental Allergy, 55(6), 481-492. 
  • Sousa-Pinto, B., Louis, R., Anto, J. M., Amaral, R., Sá-Sousa, A., Czarlewski, W., Brussino, L., Canonica, G. W., Chaves Loureiro, C., & Cruz, A. (2025). "Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study." Pulmonology, 31(1), 2416869. 
  • Sousa-Pinto, B., Savouré, M., Vieira, R. J., Amaral, R., Czarlewski, W., Bedbrook, A., Valiulis, A., Kvedariene, V., Brussino, L., & Gemicioglu, B. (2025). "Allergic rhinitis and its impact on asthma (ARIA) classes in MASK-air users." Journal of investigational allergology & clinical immunology, 1-11. 
  • Sousa-Pinto, B., Schleich, F., Louis, G., Gemicioglu, B., Kvedarienė, V., Regateiro, F. S., Chaves Loureiro, C., Taborda-Barata, L., Amaral, R., & Antó, J. M. (2025). "Daily digital biomarkers in the follow-up and clustering of patients with asthma." Pulmonology, 31(1), 2532980. 
  • Sousa‐Pinto, B., Costa, E. M., Vieira, R. J., Klimek, L., Czarlewski, W., Pfaar, O., Bedbrook, A., Amaral, R., Brussino, L., & Kvedariene, V. (2025). "Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study." Clinical & Experimental Allergy, 55(3), 226-238. 
  • Sousa‐Pinto, B., Ramanauskaite, A., Neisinger, S., Witte‐Händel, E., Gimenez‐Arnau, A. M., Guillet, C., Parisi, C. A. S., Katelaris, C. H., Fomina, D., & Larenas‐Linnemann, D. (2025). "Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study." Allergy, 80(3), 750-761. 
  • Sousa‐Pinto, B., Vieira, R. J., Bognanni, A., Gil‐Mata, S., Ferreira‐da‐Silva, R., Ferreira, A., Cardoso‐Fernandes, A., Ferreira‐Cardoso, H., Marques‐Cruz, M., & Duarte, V. H. (2025). "Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis." Allergy, 80(1), 94-105. 
  • Steinert, C., Pashuk, M., Kolkhir, P., Kocatürk, E., & Xiang, Y.-K. (2025). "Autoallergy and what the Allergist Needs to know." Current Allergy and Asthma Reports, 25(1), 1-12. 
  • Stevanovic, K., Pereira, M., Nguyen, O., van Hofman, I., Meesch, C., & Zuberbier, T. (2025). "20 years of the socioeconomic impact of atopic dermatitis and alopecia areata from around the globe." Clinical and Translational Allergy, 15(5), e70061. 
  • Stevanovic, K., Sinkkonen, A., Pawankar, R., & Zuberbier, T. (2025). "Urban greening and pollen allergy: balancing health and environmental sustainability." The Journal of Allergy and Clinical Immunology: In Practice, 13(2), 275-279. 
  • Stolz, J., Salameh, P., Asero, R., Kocatürk, E., Peter, J., Grattan, C., Herzog, L. S., Muñoz, M., Dissemond, J., & Staubach-Renz, P. (2025). "Parameters linked with higher itch severity in chronic spontaneous urticaria—chronic urticaria registry results." The Journal of Allergy and Clinical Immunology: In Practice, 13(9), 2349-2360. e2343. 
  • Treudler, R., Worm, M., Bauer, A., Dickel, H., Heine, G., Jappe, U., Klimek, L., Raulf, M., Wedi, B., & Wieczorek, D. (2025). "Berufsbedingte Anaphylaxie–Positionspapier der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)." Allergologie, 48(2025), 1-20. 
  • TURK, M., Baysal, B., Ertas, R., SALMAN, A., & Kocaturk, E. (2025). "Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic." Asthma Allergy Immunology/Astim Allerji Immunoloji, 23(1). 
  • Xiang, Y.-K., Hu, M., Elieh-Ali-Komi, D., Salman, A., Smola, A., & Kocatürk, E. (2025). "Biomarkers in Chronic Spontaneous Urticaria: Are We Ready for its Use in Clinical Practice?" Current Treatment Options in Allergy, 12(1), 15. 
  • Xiang, Y. K., & Kocatürk, E. (2025). "Diagnostic workup in paradoxical urticaria induced by H1‐antihistamines." Journal of the European Academy of Dermatology and Venereology, 39(4), 723. 
  • Zeidler, C., Stahl, L., Ständer, S., Loewenthal, J., Weller, K., Salameh, P., Metz, M., & Pereira, M. (2025). "The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real-world study." Journal of the European Academy of Dermatology and Venereology: JEADV. 
  • Zhang, D. G., Nielsen, M. L., Sørensen, J. A., Naassan, S., Vestergaard, C., Kocatürk, E., Ali, Z., Thyssen, J. P., Egeberg, A., & Thomsen, S. F. (2025). "Omalizumab dosing patterns and drug survival in adult patients with chronic spontaneous urticaria." Journal of the European Academy of Dermatology and Venereology. 
  • Zuraw, B. L., Bork, K., Bouillet, L., Christiansen, S. C., Farkas, H., Germenis, A. E., Grumach, A. S., Kaplan, A., López-Lera, A., & Magerl, M. (2025). "Hereditary angioedema with normal C1 inhibitor: an updated International consensus paper on diagnosis, pathophysiology, and treatment." Clinical reviews in allergy & immunology, 68(1), 24. 

 

2024

  • Akin, C., Siebenhaar, F., Wechsler, J. B., Youngblood, B. A., & Maurer, M. (2024). "Detecting changes in mast cell numbers versus activation in human disease: a roadblock for current biomarkers?" The Journal of Allergy and Clinical Immunology: In Practice, 12(7), 1727-1737. 
  • Akula, S., Alvarado-Vazquez, A., Haide Mendez Enriquez, E., Bal, G., Franke, K., Wernersson, S., Hallgren, J., Pejler, G., Babina, M., & Hellman, L. (2024). "Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics." International Journal of Molecular Sciences, 25(23), 13050. 
  • Akula, S., Tripathi, S. R., Franke, K., Wernersson, S., Babina, M., & Hellman, L. (2024). "Cultures of Human Skin Mast Cells, an Attractive In Vitro Model for Studies of Human Mast Cell Biology." Cells, 13(1), 98. 
  • Ali, Z., Sørensen, J. A., Zhang, D. G., Ghazanfar, M. N., Allerup, J. A. C., Maurer, M., Kocatürk, E., Vestergaard, C., & Thomsen, S. F. (2024). "Smartphone photographs of chronic urticaria taken by patients are of good quality and useful in the clinic." Dermatology, 240(3), 357-361. 
  • Atik, Ö., Tepetam, F. M., Özden, Ş., & Kocatürk, E. (2024). "Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticaria." Libyan Journal of Medicine, 19(1), 2420483. 
  • Baskurt, D., Sarac, E., Asero, R., & Kocatürk, E. (2024). "D-dimer levels decline after immunosuppressive treatment rather than anticoagulant treatment in severe autoimmune chronic spontaneous urticaria." Eur Ann Allergy Clin Immunol, 56(1), 42-44. 
  • Bergmann, K.-C., Hartung, T., Kugler, S., Stevanovic, K., & Zuberbier, T. (2024). "Long-term evaluation of Omalizumab therapy in patients with severe allergic asthma." Exploration of Asthma & Allergy, 2(4), 319-328. 
  • Bergmann, K.-C., Hartung, T., & Zuberbier, T. (2024). "Individual wearable air purifier protects against pollen, house dust mite, and cat allergens: Report from an allergen exposure chamber." Allergologie Select, 8, 70. 
  • Bizjak, M., Košnik, M., Asero, R., Kocatürk, E., Giménez Arnau, A. M., & Maurer, M. (2024). "Lymphopenia in chronic spontaneous urticaria is linked to basopenia and eosinopenia." 
  • Bousquet, J., Gherasim, A., de Blay, F., Mathieu‐Dupas, E., Batot, G., Laune, D., Sousa‐Pinto, B., Zuberbier, T., Pham‐Thi, N., & group, M. c. s. (2024). "Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air® app." Clinical and translational allergy, 14(5), e12353. 
  • Bousquet, J., Schünemann, H. J., Sousa-Pinto, B., Zuberbier, T., Togias, A., Samolinski, B., Bedbrook, A., Czarlewski, W., Hofmann-Apitius, M., & Litynska, J. (2024). "Concepts for the development of person-centered, digitally enabled, artificial intelligence–assisted ARIA care pathways (ARIA 2024)." The Journal of Allergy and Clinical Immunology: In Practice, 12(10), 2648-2668. e2642. 
  • Bousquet, J., Sousa-Pinto, B., Anto, J. M., Bedbrook, A., Fonseca, J. A., Zuberbier, T., Czarlewski, W., Haahtela, T., Canonica, G. W., & Costa, E. M. (2024). "MASK-air: an OECD (Organisation for Economic Co-operation and Development) best practice for public health on integrated care for chronic diseases." The Journal of Allergy and Clinical Immunology: In Practice, 12(8), 2010-2016. e2017. 
  • Brozek, J., Borowiack, E., Sadowska, E., Nowak, A., Sousa‐Pinto, B., Vieira, R. J., Bognanni, A., Yepes Nunez, J. J., Zhang, Y., & Zuberbier, T. (2024). "Patients' values and preferences for health states in allergic rhinitis—an artificial intelligence supported systematic review." Allergy, 79(7), 1812-1830. 
  • Buttgereit, T., Aulenbacher, F., Gutsche, A., Kolkhir, P., Weller, K., Vera Ayala, C., Magerl, M., Farkas, H., Grumach, A., & Aygören‐Pürsün, E. (2024). "The Chronic Angioedema Registry (CARE): rationale, methods and implementation." Clinical & Experimental Allergy, 54(9), 712-716. 
  • Buttgereit, T., & Magerl, M. (2024). "Klinik, Diagnostik und Therapie mastzellvermittelter Angioödeme." Allergologie, 47(11), 663. 
  • Buttgereit, T., Vera Ayala, C., Aykanat, S., Weller, K., Gutsche, A., Maurer, M., & Magerl, M. (2024). "The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center." Frontiers in Immunology, 15, 1405317. 
  • Can, P. K., Kızıltaç, U., Cüre, K., Singer, R., Degirmentepe, E. N., & Kocaturk, E. (2024). "Evaluation of the effect of adding probiotic supplementation in patients with chronic spontaneous urticaria." Dermatologica Sinica, 42(4), 280-286. 
  • CAN, P. K., & KOCATURK, E. (2024). "Symptomatic Dermographism Versus Chronic Spontaneous Urticaria; A Detailed Analysis of Clinical Features, Treatment Responses, and Comorbidities." Asthma Allergy Immunology/Astim Allerji Immunoloji, 22(3). 
  • Chernyshov, P., Finlay, A., Tomas‐Aragones, L., Zuberbier, T., Kocatürk, E., Manolache, L., Pustisek, N., Svensson, A., Marron, S., & Sampogna, F. (2024). "Quality of life measurement in urticaria: position statement of the European Academy of Dermatology and Venereology task forces on quality of life and patient‐oriented outcomes and urticaria and angioedema." Journal of the European Academy of Dermatology and Venereology, 38(11), 2056-2072. 
  • Chernyshov, P. V., Tomas‐Aragones, L., Zuberbier, T., Kocatürk, E., Manolache, L., Pustisek, N., Svensson, Å., Marron, S. E., Sampogna, F., & Bewley, A. (2024). "Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement." International Journal of Dermatology, 63(12), 1657-1667. 
  • Cherrez-Ojeda, I., Bousquet, J., Giménez-Arnau, A., Godse, K., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., & Allenova, A. (2024a). "Patient-reported outcome measures in atopic dermatitis and chronic urticaria are underused in clinical practice." The Journal of Allergy and Clinical Immunology: In Practice, 12(6), 1575-1583. e1571. 
  • Cherrez-Ojeda, I., Bousquet, J., Giménez-Arnau, A., Godse, K., Krasowska, D., Bartosińska, J., Szczepanik-Kułak, P., Wawrzycki, B., Kolkhir, P., & Allenova, A. (2024b). "Usage prevalence of angioedema patient–reported outcome measures: Results from the UCARE and ACARE PROMUSE study." The Journal of Allergy and Clinical Immunology: In Practice, 12(8), 2211-2215. e2211. 
  • Christou, D., Stevanovic, K., Evers, S., Weide, M., & Zuberbier, T. (2024). "Evaluating the Impact of Laundry Detergents on the Skin Microbiome of Atopic Dermatitis Patients—A Clinical Study." Health Science Reports, 7(12), e70261. 
  • Craig, T. J., Levy, D. S., Reshef, A., Lumry, W. R., Martinez-Saguer, I., Jacobs, J. S., Yang, W. H., Ritchie, B., Aygören-Pürsün, E., & Keith, P. K. (2024). "Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study." The Lancet Haematology, 11(6), e436-e447. 
  • Daci, D., Altrichter, S., Grillet, F. M., Dib, S., Mouna, A., Suresh Kumar, S., Terhorst-Molawi, D., Maurer, M., Günzel, D., & Scheffel, J. (2024). "Altered Sweat Composition Due to Changes in Tight Junction Expression of Sweat Glands in Cholinergic Urticaria Patients." International journal of molecular sciences, 25(9), 4658. 
  • Demir, S., Eyice‐Karabacak, D., Kocatürk, E., Ünal, D., Toprak, İ. D., Korkmaz, P., Aslan, A. F., İmren, I. G., Dikicier, B., & Kahveci, N. (2024). "Monitoring recurrent angioedema: Findings from the Turkish angioedema control test validation study." Clinical and translational allergy, 14(3), e12342. 
  • Fluhr, J. W., Herzog, L., Darlenski, R., Mentel, T., & Zuberbier, T. (2024). "Short-term Heat Application Reduces Itch Intensity in Atopic Dermatitis: Insights from Mechanical Induction and Real-life Episodes." Acta Dermato-Venereologica, 104, 40127. 
  • Fluhr, J. W., Voisard, A., Nikolaeva, D. G., Herzog, L., Wiora, G., Gayer, J., Lehmann, N. J., & Darlenski, R. (2024). "Stratum corneum hydration measurements with a Bluetooth wireless probe: A real-life study at home compared to measurements under laboratory conditions." Skin pharmacology and physiology, 37(1-3), 40-48. 
  • Ghazanfar, M. N., Petrosius, V., Sørensen, J. A., Zhang, D. G., Ali, Z., Maurer, M., Kocatürk, E., Nielsen, V. W., Savickas, S., & Schoof, E. M. (2024). "Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment." Allergy, 79(9). 
  • Grattan, C. E., & Kocatürk, E. (2024). "How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab." British Journal of Dermatology, 191(2), 153-154. 
  • Gutsche, A., Metz, M., Munoz, M., Wong, K., Omachi, T., Zhao, R., Maurer, M., Zampeli, V., & Magerl, M. (2024). "Assessing the reliability of the FricTest® 4.0 for diagnosing symptomatic dermographism." Clinical and Translational Allergy, 14(11), e70005. 
  • Hu, M., Scheffel, J., Frischbutter, S., Steinert, C., Reidel, U., Spindler, M., Przybyłowicz, K., Hawro, M., Maurer, M., & Metz, M. (2024). "Characterization of cells and mediators associated with pruritus in primary cutaneous T-cell lymphomas." Clinical and Experimental Medicine, 24(1), 171. 
  • Jappe, U., Bergmann, K.-C., Brinkmann, F., Faihs, V., Gülsen, A., Klimek, L., Renz, H., Seurig, S., Taube, C., & Traidl, S. (2024). "Biologics in allergology and clinical immunology: Update on therapies for atopic diseases, urticaria, and angioedema and on safety aspects focusing on hypersensitivity reactions." Allergologie Select, 8, 365. 
  • Klimek, L., Siebenhaar, F., Staubach, P., Jakob, T., Bauer, A., Pfützner, W., Wedi, B., Arasi, S., Hagemann, J., & Hötzenecker, W. (2024). "Wissenschaftler, Mentor, Lehrer, Arzt-ein inspirierender und wunderbarer Mensch ist von uns gegangen." In: Springer.
  • Klimek, L., Zuberbier, T., Siebenhaar, F., Staubach, P., Jakob, T., Bauer, A., Pfützner, W., Wedi, B., Del Giacco, S., & Bonadonna, P. (2024). "Obituary: Professor Marcus Maurer, Berlin, Germany." Allergy. 
  • Kocatürk, E., & Maurer, M. (2024). "Acute urticaria management: Gaps, challenges and the need for further evidence." Journal of the European Academy of Dermatology and Venereology, 38(11), 2047-2048. 
  • Kolkhir, P., Altrichter, S., Badloe, F. M. S., Belasri, H., Charles, N., De Vriese, S., Gutermuth, J., Huygen, L., Kocatürk, E., & Kortekaas Krohn, I. (2024). "The European network for IgE-mediated autoimmunity and autoallergy (ENIGMA) initiative." nature medicine, 30(4), 920-922. 
  • Kolkhir, P., Bonnekoh, H., Metz, M., & Maurer, M. (2024). "Chronic spontaneous urticaria: a review." Jama. 
  • Lerner, L., Babina, M., Zuberbier, T., & Stevanovic, K. (2024). "Beyond allergies—Updates on the role of mas-related G-protein-coupled receptor X2 in chronic urticaria and atopic dermatitis." Cells, 13(3), 220. 
  • Li, Z., Schneikert, J., Tripathi, S. R., Jin, M., Bal, G., Zuberbier, T., & Babina, M. (2024). "CREB Is Critically Implicated in Skin Mast Cell Degranulation Elicited via FcεRI and MRGPRX2." Cells, 13(20), 1681. 
  • Magerl, M. (2024). "Was sind Leitsymptome bei Urtikaria, und wie werden sie systematisch erfasst?" Die Dermatologie, 75(4), 274-280. 
  • Magerl, M., Martinez-Saguer, I., Schauf, L., Pohl, S., & Brendel, K. (2024). "The current situation of hereditary angioedema patients in Germany: results of an online survey." Frontiers in Medicine, 10, 1274397. 
  • Magerl, M., Schiffhorst, G., Fanter, L., Müller, G., Hirche, C., Berkemeier, F., & Aygören, E. (2024). "Patient‐level indirect treatment comparison of lanadelumab versus pdC1‐INH iv in hereditary angioedema patients: PATCH study." Allergy, 79(1), 215-224. 
  • Maurer, M., Bonnekoh, H., Grekowitz, E., Kiefer, L., Munoz, M., Pereira, M. P., & Terhorst‐Molawi, D. (2024). "An algorithm for the diagnosis and treatment of chronic inducible urticaria, 2024 update." In: Wiley Online Library.
  • Maurer, M., Kolkhir, P., Pereira, M. P., Siebenhaar, F., Witte‐Händel, E., Bergmann, K. C., Bonnekoh, H., Buttgereit, T., Fluhr, J. W., & Frischbutter, S. (2024). "Disease modification in chronic spontaneous urticaria." Allergy, 79(9), 2396-2413. 
  • Maurer, M., Pereira, M. P., & Kolkhir, P. (2024). "The definition, classification, and history of urticaria." Immunology and Allergy Clinics, 44(3), 407-419. 
  • Metz, M., Kolkhir, P., Altrichter, S., Siebenhaar, F., Levi‐Schaffer, F., Youngblood, B. A., Church, M. K., & Maurer, M. (2024). "Mast cell silencing: a novel therapeutic approach for urticaria and other mast cell‐mediated diseases." Allergy, 79(1), 37-51. 
  • Metz, M., Zeidler, C., Hawro, T., Pereira, M., Maurer, M., Bonnekoh, H., Krause, K., Pritchard, T., Kwatra, S. G., & Ständer, S. (2024). "Development and validation of a patient-reported outcome measure to assess disease control in chronic prurigo." JAMA dermatology, 160(2), 187-193. 
  • Mihlan, M., Wissmann, S., Gavrilov, A., Kaltenbach, L., Britz, M., Franke, K., Hummel, B., Imle, A., Suzuki, R., & Stecher, M. (2024). "Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay." Cell, 187(19), 5316-5335. e5328. 
  • Moñino‐Romero, S., Kolkhir, P., Ohanyan, T., Szépfalusi, Z., Weller, K., Metz, M., Scheffel, J., Maurer, M., & Altrichter, S. (2024). "Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria." Journal of the European Academy of Dermatology and Venereology, 38(1), 167-174. 
  • Mortz, C. G., Eller, E., Garvik, O. S., Kjaer, H. F., Zuberbier, T., & Bindslev‐Jensen, C. (2024). "Challenge‐verified thresholds for allergens mandatory for labeling: How little is too much for the most sensitive patient?" Allergy, 79(5), 1306-1316. 
  • Muñoz, M., Kiefer, L. A., Pereira, M. P., Bizjak, M., & Maurer, M. (2024). "New insights into chronic inducible urticaria." Current Allergy and Asthma Reports, 24(8), 457-469. 
  • Muñoz, M., Kocatürk, E., Maurer, M., & Kolkhir, P. (2024). "Emerging therapeutics in chronic urticaria." Immunology and Allergy Clinics, 44(3), 517-528. 
  • Muñoz, M., & Siebenhaar, F. (2024). "Mastozytose–eine häufig unerkannte Erkrankung." best practice onkologie, 19(5), 206-217. 
  • Muraro, A., de Silva, D., Podesta, M., Anagnostou, A., Cardona, V., Halken, S., Smith, P., Tanno, L. K., Turner, P., & Worm, M. (2024). "10 practical priorities to prevent and manage serious allergic reactions: GA2LEN ANACare and EFA Anaphylaxis Manifesto." Clinical and translational allergy, 14(12), e70009. 
  • Neisinger, S., Sousa Pinto, B., Ramanauskaite, A., Bousquet, J., Weller, K., Metz, M., Magerl, M., Kocatürk, E., Cherrez‐Ojeda, I., & Gimenez‐Arnau, A. M. (2024). "CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria." Clinical and translational allergy, 14(1), e12328. 
  • Neustädter, I., Blatt, S., Wurpts, G., Dickel, H., Walter, C., Aberer, W., Bode, S., Buhl, T., Gernert, S., & Harner, S. (2024). "“Delabeling” by direct provocation testing in children and adolescents with a suspected history of a delayed reaction to β-lactam antibiotics: Consensus paper of Gesellschaft für pädiatrische Allergologie und Umweltmedizin (GPAU), Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI), and Ärzteverband deutscher Allergologen (ÄDA)." Allergologie select, 8, 206. 
  • Oliveira, C. C., Charalampous, P., Delaye, J., Grad, D. A., Kolkhir, P., Mechili, E. A., Unim, B., Devleesschauwer, B., & Haagsma, J. A. (2024). "A systematic review of studies that estimated the burden of chronic non-communicable rare diseases using disability-adjusted life years." Orphanet Journal of Rare Diseases, 19(1), 333. 
  • Ornek Ozdemir, S., Can, P. K., Degirmentepe, E. N., Kızıltaç, K., Singer, R., & Kocatürk, E. (2024). "Unveiling treatment response predictors in predominant subtypes of chronic Inducible Urticaria." International Archives of Allergy and Immunology, 185(11), 1055-1065. 
  • Ornek Ozdemir, S., Kuteyla Can, P., Degirmentepe, E., Cure, K., Singer, R., & Kocaturk, E. (2024). "A comparative analysis of chronic inducible urticaria in 423 patients: clinical and laboratory features and comorbid conditions." Journal of the European Academy of Dermatology and Venereology, 38(3), 513-520. 
  • Örnek, S., Ozekinci, S., Ipin, T., & Kocaturk, E. (2024). "TOX, TWIST1, STAT4, and SATB1 protein expressions in early‐stage mycosis fungoides." Journal of Cutaneous Pathology, 51(3), 232-238. 
  • Pankow, A., Bonnekoh, H., Krusche, M., & Ohrndorf, S. (2024). "Diseases in old age: polymyalgia rheumatica, giant cell arteritis, Schnitzler syndrome and VEXAS syndrome." AKTUELLE RHEUMATOLOGIE, 49(05), 310-316. 
  • Papadopoulos, N. G., Akdis, C. A., Akdis, M., Damialis, A., Esposito, G., Fergadiotou, I., Goroncy, C., Guitton, P., Gotua, M., & Erotokritou, K. (2024). "Addressing adverse synergies between chemical and biological pollutants at schools—The ‘SynAir‐G’hypothesis." Allergy, 79(2), 294-301. 
  • Petersen, R. S., Fijen, L. M., Apfelbacher, C., Magerl, M., Weller, K., Aberer, W., Adatia, A., Audhya, P., Bara, N.-A., & Betschel, S. (2024). "A core outcome set for efficacy of acute treatment of hereditary angioedema." The Journal of Allergy and Clinical Immunology: In Practice, 12(6), 1614-1621. 
  • Pfaar, O., Sousa‐Pinto, B., Papadopoulos, N. G., Larenas‐Linnemann, D. E., Ordak, M., Torres, M. J., Mösges, R., Klimek, L., Zuberbier, T., & Matricardi, P. M. (2024). "Digitally‐enabled, person‐centred care (PCC) in allergen immunotherapy: An ARIA‐EAACI Position Paper." Allergy, 79(8), 2037-2050. 
  • Podder, I., Salman, A., Asero, R., Teresa Caballero, M., Caffarelli, C., De las Vecillas, L., Gimenez-Arnau, A. M., Giovannini, M., Kocatürk, E., & Kolkhir, P. (2024). "Biological drugs for the treatment of children with chronic spontaneous urticaria." Expert Review of Clinical Immunology, 20(12), 1427-1435. 
  • Pyatilova, P., Hackler, Y., Aulenbacher, F., Asero, R., Bauer, A., Bizjak, M., Day, C., Dissemond, J., Du-Thanh, A., & Fomina, D. (2024). "Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry." The Journal of Allergy and Clinical Immunology: In Practice, 12(7), 1890-1899. e1893. 
  • Reshef, A., Buttgereit, T., Betschel, S. D., Caballero, T., Farkas, H., Grumach, A. S., Hide, M., Jindal, A. K., Longhurst, H., & Peter, J. (2024). "Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus." Journal of Allergy and Clinical Immunology, 154(2), 398-411. e391. 
  • Rommel, F. R., Tumala, S., Urban, A.-L., Siebenhaar, F., Kruse, J., Gieler, U., & Peters, E. M. (2024). "Stress Affects Mast Cell Proteases in Murine Skin in a Model of Atopic Dermatitis-like Allergic Inflammation." International journal of molecular sciences, 25(11), 5738. 
  • Rubeiz, C. J., Asero, R., Betschel, S., Craig, T., Grumach, A., Hide, M., Lang, D., Levin, M., Longhurst, H., & Magan, E. (2024). "Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria." World Allergy Organization Journal, 17(1), 100858. 
  • Sadeghi, H., Ghaffari, J., Rajabi, J., Golpour, M., Zuberbier, T., Fattahi, S., Asgarian-Omran, H., & Rafiei, A. (2024). "Evaluation of the Immune Checkpoints, TIM-3 and PD-1, as well as Anti-Inflammatory Cytokines IL-10, and TGF-β along with Diseases Activity in Chronic Spontaneous Urticaria." International Journal of Molecular and Cellular Medicine, 13(1), 64. 
  • Salameh, P., Gutsche, A., Aulenbacher, F., Buttgereit, T., Weller, K., Siebenhaar, F., & Maurer, M. (2024). "Urticaria Control Test real‐world performance: A post‐hoc analysis." Allergy, 79(1). 
  • Siiskonen, H., Fok, J., Buscone, S., Castellano Pellicena, I., Uzunbajakava, N., Botchkareva, N., Maurer, M., & Scheffel, J. (2024). "Human skin mast cells express photoreceptors." Journal of the European Academy of Dermatology & Venereology, 38(7). 
  • Sindher, S. B., Fiocchi, A., Zuberbier, T., Arasi, S., Wood, R. A., & Chinthrajah, R. S. (2024). "The role of biologics in the treatment of food allergy." The Journal of Allergy and Clinical Immunology: In Practice, 12(3), 562-568. 
  • Soegiharto, R., Aghdam, M. A., Sørensen, J. A., Van Lindonk, E., Demir, F. B., Porras, N. M., Matsuo, Y., Kiefer, L., Knulst, A. C., & Maurer, M. (2024). "Multinational drug survival study of omalizumab in patients with chronic urticaria and potential predictors for discontinuation." JAMA dermatology, 160(9), 927-935. 
  • Sousa-Pinto, B., Vieira, R. J., Brozek, J., Cardoso-Fernandes, A., Lourenço-Silva, N., Ferreira-da-Silva, R., Ferreira, A., Gil-Mata, S., Bedbrook, A., & Klimek, L. (2024). "Intranasal antihistamines and corticosteroids in allergic rhinitis: a systematic review and meta-analysis." Journal of Allergy and Clinical Immunology, 154(2), 340-354. 
  • Sousa-Pinto, B., Vieira, R. J., Marques-Cruz, M., Bognanni, A., Gil-Mata, S., Jankin, S., Amaro, J., Pinheiro, L., Mota, M., & Giovannini, M. (2024). "Artificial Intelligence–Supported Development of Health Guideline Questions." Annals of Internal Medicine, 177(11), 1518-1529. 
  • Sousa‐Pinto, B., Louis, G., Vieira, R. J., Czarlewski, W., Anto, J. M., Amaral, R., Sá‐Sousa, A., Brussino, L., Canonica, G. W., & Loureiro, C. C. (2024). "Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study." Clinical and Translational Allergy, 14(6), e12358. 
  • Sousa‐Pinto, B., Valiulis, A., Melén, E., Koppelman, G. H., Papadopoulos, N. G., Makela, M., Haahtela, T., Bonini, M., Braido, F., & Brussino, L. (2024). "Asthma and rhinitis control in adolescents and young adults: a real‐world MASK‐air study." Pediatric Allergy and Immunology, 35(2), e14080. 
  • Tong, X., Zhang, X., Wang, M., Wang, Z., Dong, F., Gong, E., Zuberbier, T., & Li, Y. (2024). "Non‐pharmacological interventions for asthma prevention and management across the life course: Umbrella review." Clinical and translational allergy, 14(3), e12344. 
  • Torres, M. I., Gil-Mata, S., Bognanni, A., Ferreira-da-Silva, R., Yepes-Nuñez, J. J., Lourenço-Silva, N., Cardoso-Fernandes, A., Ferreira, A., Ferreira-Cardoso, H., & Portela, D. (2024). "Intranasal versus oral treatments for allergic rhinitis: A systematic review with meta-analysis." The Journal of Allergy and Clinical Immunology: In Practice, 12(12), 3404-3418. 
  • Treudler, R., Worm, M., Bauer, A., Dickel, H., Heine, G., Jappe, U., Klimek, L., Raulf, M., Wedi, B., & Wieczorek, D. (2024). "Occupational anaphylaxis: A position paper of the German Society of Allergology and Clinical Immunology (DGAKI)." Allergologie Select, 8, 407. 
  • Türk, M., Kocatürk, E., Ertaş, R., Ensina, L. F., Mariel Ferrucci, S., Grattan, C., Vestergaard, C., Zuberbier, T., Maurer, M., & Giménez‐Arnau, A. M. (2024). "A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown‐CSU study." Clinical and translational allergy, 14(2), e12343. 
  • Turner, P. J., Bognanni, A., Arasi, S., Ansotegui, I. J., Schnadt, S., La Vieille, S., Hourihane, J. O. B., Zuberbier, T., Eigenmann, P., & Ebisawa, M. (2024). "Time to ACT-UP: Update on precautionary allergen labelling (PAL)." World Allergy Organization Journal, 17(10), 100972. 
  • Valent, P., Hartmann, K., Hoermann, G., Reiter, A., Alvarez-Twose, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., & Carter, M. C. (2024). "Harmonization of diagnostic criteria in mastocytosis for use in clinical practice: WHO vs ICC vs AIM/ECNM." The Journal of Allergy and Clinical Immunology: In Practice, 12(12), 3250-3260. e3255. 
  • Valerieva, A., Caballero, T., Magerl, M., Frade, J. P., Audhya, P. K., & Craig, T. (2024). "Advent of oral medications for the treatment of hereditary angioedema." Clinical and Translational Allergy, 14(9), e12391. 
  • Vassilopoulou, E., Comotti, A., Douladiris, N., Konstantinou, G. Ν., Zuberbier, T., Alberti, I., Agostoni, C., Berni Canani, R., Bocsan, I. C., & Corsello, A. (2024). "A systematic review and meta‐analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report." Allergy, 79(7), 1708-1724. 
  • Vieira, R., Pereira, A., Papadopoulos, N., Zuberbier, T., Pham-Thi, N., Giovannini, M., Melén, E., Azevedo, L., Fonseca, J., & Bousquet, J. (2024). "Impact of Allergic Rhinitis on Academic Performance in Adolescents and Adults: a Bayesian Analysis of MASK-air® Real-world Direct Patient Data." Journal of investigational allergology & clinical immunology, 34(6), 409-411. 
  • Vieira, R. J., Leemann, L., Briggs, A., Pereira, A. M., Savouré, M., Kuna, P., Morais-Almeida, M., Bewick, M., Azevedo, L. F., & Louis, R. (2024). "Poor rhinitis and asthma control is associated with decreased health-related quality of life and utilities: a MASK-air study." The Journal of Allergy and Clinical Immunology: In Practice, 12(6), 1530-1538. e1536. 
  • Vieira, R. J., Sousa‐Pinto, B., Bognanni, A., Yepes‐Nuñez, J. J., Zhang, Y., Lityńska, J., Sadowska, E., Borowiack, E., Samolinski, B., & Togias, A. (2024). "Embedding patients' values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024." Clinical and translational allergy, 14(6), e12377. 
  • Vieira, R. J., Torres, M. I., Bognanni, A., Gil-Mata, S., Ferreira-da-Silva, R., Lourenço-Silva, N., Cardoso-Fernandes, A., Ferreira, A., Ferreira-Cardoso, H., & Teles, J. (2024). "Protocol for the systematic reviews on the desirable and undesirable effects of pharmacological treatments of allergic rhinitis informing the ARIA 2024 guidelines." Allergologie Select, 8, 270. 
  • Wedi, B., & Magerl, M. (2024). "Es juckt und schwillt–aber nicht nur…." Die Dermatologie, 75(4), 271-273. 
  • Xiang, Y.-K., Fok, J. S., Podder, I., Yücel, M. B., Özkoca, D., Thomsen, S. F., & Kocatürk, E. (2024). "An update on the use of antihistamines in managing chronic urticaria." Expert opinion on pharmacotherapy, 25(5), 551-569. 
  • Xiang, Y.-K., Türk, M., Ojeda, I. C., Elieh-Ali-Komi, D., Salman, A., & Kocatürk, E. (2024). "Psychological stress and urticaria: pathophysiologic and therapeutic updates." Current Treatment Options in Allergy, 11(4), 194-210. 
  • Zeng, B., Domarecka, E., Kong, L., Olze, H., Scheffel, J., Moñino-Romero, S., Siebenhaar, F., & Szczepek, A. J. (2024). "A systematic review of the clinical evidence for an association between type I hypersensitivity and inner ear disorders." Frontiers in Neurology, 15, 1378276. 
  • Zhang, D. G., Sørensen, J. A., Ghazanfar, M. N., & Thomsen, S. F. (2024). "Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes." Allergy, 79(1). 
  • Zhang, D. G., Sørensen, J. A., Pedersen, N. H., Ali, Z., Kocatürk, E., Maurer, M., & Thomsen, S. F. (2024). "Online depiction of urticaria is often flawed and does not reflect the spectrum of clinical manifestation." Dermatology, 240(3), 507-513. 
  • Zuberbier, T., Ensina, L. F., Giménez-Arnau, A., Grattan, C., Kocatürk, E., Kulthanan, K., Kolkhir, P., & Maurer, M. (2024). "Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment." The Lancet, 404(10450), 393-404. 
  • Zuberbier, T., Muraro, A., Nurmatov, U., Arasi, S., Stevanovic, K., Anagnostou, A., Bonaguro, R., Chinthrajah, S., Lack, G., & Fiocchi, A. (2024). "GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management." Clinical and translational allergy, 14(11), e70002. 
  • Zuberbier, T., Stevanovic, K., Ansotegui, I. J., Anto, J. M., Bergmann, K.-C., D’Amato, G., Grüntuch-Ernst, A., Haahtela, T., Maurer, M., & Pietikäinen, S. (2024). "Green Roof Gardens–Selecting Allergy-Friendly Vegetation: A Global Allergy and Asthma Excellence Network (GA²LEN) Position Paper." The Journal of Allergy and Clinical Immunology: In Practice, 12(2), 347-354. 

 

2023

  • Bonnekoh H., Krause K., & Kolkhir P. (2023). "Chronic recurrent wheals–If not chronic spontaneous urticaria, what else?" Allergologie Select, 7, 8.
  • Bonnekoh H., Krause K., & Kolkhir P. (2023). "Chronisch rezidivierend auftretende Quaddeln–Woran sollte neben einer chronischen spontanen Urtikaria gedacht werden?" Allergologie, 46(1), 41.
  • Charalampous P., Haagsma J. A., Jakobsen L. S., Gorasso V., Noguer I., Padron-Monedero A., Sarmiento R., Santos J. V., McDonald S. A., & Plass D. (2023). "Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices." Epidemiology & Infection, 1-32.
  • Craig T. J., Reshef A., Li H. H., Jacobs J. S., Bernstein J. A., Farkas H., Yang W. H., Stroes E. S. G., Ohsawa I., Tachdjian R., Manning M. E., Lumry W. R., Saguer I. M., Aygören-Pürsün E., Ritchie B., Sussman G. L., Anderson J., Kawahata K., Suzuki Y., Staubach P., Treudler R., Feuersenger H., Glassman F., Jacobs I., & Magerl M. (2023). "Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial." The Lancet, 401(10382), 1079-1090. doi:https://doi.org/10.1016/S0140-6736(23)00350-1
  • Förster-Ruhrmann U., Stergioudi D., Szczepek A. J., Fluhr J. W., Zuberbier T., Olze H., & Bergmann K.-C. (2023). "A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics." World Allergy Organization Journal, 16(2), 100746. doi:https://doi.org/10.1016/j.waojou.2023.100746
  • Franke K., Bal G., Li Z., Zuberbier T., & Babina M. (2023). "CREB Is Activated by the SCF/KIT Axis in a Partially ERK-Dependent Manner and Orchestrates Survival and the Induction of Immediate Early Genes in Human Skin Mast Cells." International Journal of Molecular Sciences, 24(4), 4135. Retrieved from https://www.mdpi.com/1422-0067/24/4/4135
  • Frischbutter S., Durek P., Witkowski M., Angermair S., Treskatsch S., Maurer M., Radbruch A., & Mashreghi M.-F. (2023). "Serum TGF-β as a predictive biomarker for severe disease and fatality of COVID-19." European Journal of Immunology, 53(10), 2350433. doi:https://doi.org/10.1002/eji.202350433
  • Klimek L., Brehler R., Bergmann K.-C., Casper I., Klimek F., Hagemann J., Polk M.-L., & Cuevas M. (2023). "Avoidance measures for mite allergy—an update." Allergo Journal International, 32(1), 18-27.
  • Klimek L., Brehler R., Casper I., Klimek F., Hagemann J., Cuevas M., & Bergmann K.-C. (2023). "Allergen immunotherapy in house dust mite-associated allergic rhinitis: efficacy of the 300 IR mite tablet." Allergo Journal International, 32(1), 10-17.
  • Krišto M., Lugović-Mihić L., Muñoz M., Rupnik M., Mahnic A., Ozretić P., Jaganjac M., Ćesić D., & Kuna M. (2023). "Gut Microbiome Composition in Patients with Chronic Urticaria: A Review of Current Evidence and Data." Life, 13(1), 152.
  • Özçeker D., Can P. K., Terzi Ö., Ornek S. A., Değirmentepe Ece N., Kızıltac K., Sarac E., & Kocatürk E. (2023). "Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response." Pediatric Allergy and Immunology, 34(2), e13925. doi:https://doi.org/10.1111/pai.13925
  • Sousa-Pinto B., Jácome C., Pereira A. M., Regateiro F. S., Almeida R., Czarlewski W., Kulus M., Shamji M. H., Boulet L.-P., & Bonini M. (2023). "Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study." The Lancet Digital Health, 5(4), e227-e238.
  • Sousa-Pinto B., Schünemann H. J., Sá-Sousa A., Vieira R. J., Amaral R., Anto J. M., Klimek L., Czarlewski W., Mullol J., Pfaar O., Bedbrook A., Brussino L., Kvedariene V., Larenas-Linnemann D. E., Okamoto Y., Ventura M. T., Agache I., Ansotegui I. J., Bergmann K. C., Bosnic-Anticevich S., Canonica G. W., Cardona V., Carreiro-Martins P., Casale T., Cecchi L., Chivato T., Chu D. K., Cingi C., Costa E. M., Cruz A. A., Del Giacco S., Devillier P., Eklund P., Fokkens W. J., Gemicioglu B., Haahtela T., Ivancevich J. C., Ispayeva Z., Jutel M., Kuna P., Kaidashev I., Khaitov M., Kraxner H., Laune D., Lipworth B., Louis R., Makris M., Monti R., Morais-Almeida M., Mösges R., Niedoszytko M., Papadopoulos N. G., Patella V., Pham-Thi N., Regateiro F. S., Reitsma S., Rouadi P. W., Samolinski B., Sheikh A., Sova M., Todo-Bom A., Taborda-Barata L., Toppila-Salmi S., Sastre J., Tsiligianni I., Valiulis A., Vandenplas O., Wallace D., Waserman S., Yorgancioglu A., Zidarn M., Zuberbier T., Fonseca J. A., & Bousquet J. (2023). "Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study." Allergy, 78(4), 968-983. doi:https://doi.org/10.1111/all.15574

2022

  • Bergmann K.-C. (2022a). "Biology of house dust mites and storage mites." Allergo Journal International, 31(8), 272-278.
  • Bergmann K.-C. (2022b). "Frequency of sensitizations and allergies to house dust mites." Allergo Journal International, 31(8), 279-283.
  • Bergmann K.-C., Skowasch D., Timmermann H., Lindner R., Virchow J. C., Schmidt O., Koschel D., Neurohr C., Heck S., & Milger K. (2022). "Prevalence of patients with uncontrolled asthma despite NVL/GINA step 4/5 treatment in Germany." Journal of Asthma and Allergy, 897-906.
  • Bölke G., Tong X., Zuberbier T., Bousquet J., & Bergmann K.-C. (2022). "Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma." World Allergy Organization Journal, 15(10), 100703.
  • Bonnekoh H., Butze M., & Metz M. (2022). "Characterization of the effects on pruritus by novel treatments for atopic dermatitis." JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20(2), 150-156.
  • Chebib S., Meng C., Ludwig C., Bergmann K.-C., Becker S., Dierend W., & Schwab W. (2022). "Identification of allergenomic signatures in allergic and well-tolerated apple genotypes using LC-MS/MS." Food Chemistry: Molecular Sciences, 4, 100111.
  • Chen Y., Ye Y., Krauß P.-L., Löwe P., Pfeiffenberger M., Damerau A., Ehlers L., Buttgereit T., Hoff P., & Buttgereit F. (2022). "Age-related increase of mitochondrial content in human memory CD4+ T cells contributes to ROS-mediated increased expression of proinflammatory cytokines." Frontiers in Immunology, 13, 911050.
  • Craig T., Magerl M., Levy D. S., Reshef A., Lumry W. R., Martinez-Saguer I., Jacobs J. S., Yang W. H., Ritchie B., & Aygören-Pürsün E. (2022). "Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial." The Lancet, 399(10328), 945-955.
  • Francuzik W., Pažur K., Dalke M., Dölle-Bierke S., Babina M., & Worm M. (2022). "Serological profiling reveals hsa-miR-451a as a possible biomarker of anaphylaxis." JCI insight, 7(7).
  • Franke K., Kirchner M., Mertins P., Zuberbier T., & Babina M. (2022). "The SCF/KIT axis in human mast cells: Capicua acts as potent KIT repressor and ERK predominates PI3K." Allergy, 77(11), 3337-3349.
  • Gazzi T., Brennecke B., Atz K., Korn C., Sykes D., Forn-Cuni G., Pfaff P., Sarott R. C., Westphal M. V., & Mostinski Y. (2022). "Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe." Chemical Science, 13(19), 5539-5545.
  • Graf M., von Stuckrad S. L., Uruha A., Klotsche J., Zorn-Pauly L., Unterwalder N., Buttgereit T., Krusche M., Meisel C., & Burmester G. R. (2022). "SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies." RMD open, 8(1), e001934.
  • Kocaturk E., Saini S. S., Rubeiz C. J., & Bernstein J. A. (2022). "Existing and investigational medications for refractory chronic spontaneous urticaria: safety, adverse effects, and monitoring." The Journal of Allergy and Clinical Immunology: In Practice.
  • Metz M., & Raap U. (2022). "Neuigkeiten aus der aktuellen Leitlinie zu chronischem Pruritus." Die Dermatologie, 73(8), 609-612.
  • Ornek S. A., Orcen C., Church M. K., & Kocaturk E. (2022). "An evaluation of remission rates with first and second line treatments and indicators of antihistamine refractoriness in chronic urticaria." International Immunopharmacology, 112, 109198.
  • Redhu D., Franke K., Aparicio-Soto M., Kumari V., Pazur K., Illerhaus A., Hartmann K., Worm M., & Babina M. (2022). "Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: Relevance of the tryptase/protease-activated receptor 2 axis." Journal of Allergy and Clinical Immunology, 149(6), 2053-2061. e2056.
  • Sousa-Pinto B., Anto A., Berger M., Dramburg S., Pfaar O., Klimek L., Jutel M., Czarlewski W., Bedbrook A., Valiulis A., Agache I., Amaral R., Ansotegui I. J., Bastl K., Berger U., Bergmann K. C., Bosnic-Anticevich S., Braido F., Brussino L., Cardona V., Casale T., Canonica G. W., Cecchi L., Charpin D., Chivato T., Chu D. K., Cingi C., Costa E. M., Cruz A. A., Devillier P., Durham S. R., Ebisawa M., Fiocchi A., Fokkens W. J., Gemicioglu B., Gotua M., Guzmán M. A., Haahtela T., Ivancevich J. C., Kuna P., Kaidashev I., Khaitov M., Kvedariene V., Larenas-Linnemann D. E., Lipworth B., Laune D., Matricardi P. M., Morais-Almeida M., Mullol J., Naclerio R., Neffen H., Nekam K., Niedoszytko M., Okamoto Y., Papadopoulos N. G., Park H. S., Passalacqua G., Patella V., Pelosi S., Nhan P. T., Popov T. A., Regateiro F. S., Reitsma S., Rodriguez-Gonzales M., Rosario N., Rouadi P. W., Samolinski B., Sá-Sousa A., Sastre J., Sheikh A., Ulrik C. S., Taborda-Barata L., Todo-Bom A., Tomazic P. V., Toppila-Salmi S., Tripodi S., Tsiligianni I., Valovirta E., Ventura M. T., Valero A. A., Vieira R. J., Wallace D., Waserman S., Williams S., Yorgancioglu A., Zhang L., Zidarn M., Zuberbier J., Olze H., Antó J. M., Zuberbier T., Fonseca J. A., & Bousquet J. (2022). "Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities." Clinical and Translational Allergy, 12(11). doi:ARTN e12208
  • 10.1002/clt2.12208
  • Sousa‐Pinto B., Anto A., Berger M., Dramburg S., Pfaar O., Klimek L., Jutel M., Czarlewski W., Bedbrook A., & Valiulis A. (2022). "Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities." Clinical and translational allergy, 12(11), e12208.
  • Ständer S., Zeidler C., Augustin M., Darsow U., Kremer A. E., Legat F. J., Koschmieder S., Kupfer J., Mettang T., & Metz M. (2022). "S2k guideline: Diagnosis and treatment of chronic pruritus." JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 20(10), 1387-1402.
  • Trendelenburg V., Dölle-Bierke S., Unterleider N., Alexiou A., Kalb B., Meixner L., Heller S., Lau S., Lee Y.-A., & Fauchère F. (2022). "Tolerance induction through non-avoidance to prevent persistent food allergy (TINA) in children and adults with peanut or tree nut allergy: rationale, study design and methods of a randomized controlled trial and observational cohort study." Trials, 23(1), 236.
  • Tsabouri S., Arasi S., Beken B., Church M. K., Alvaro‐Lozano M., Caffarelli C., Flohr C., Janmohamed S. R., Konstantinou G. N., & Lau S. (2022). "A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce." Pediatric Allergy and Immunology, 33(1), e13674.
  • Wang Z., Franke K., Bal G., Li Z., Zuberbier T., & Babina M. (2022). "MRGPRX2-mediated degranulation of human skin mast cells requires the operation of Gαi, Gαq, Ca++ channels, ERK1/2 and PI3K—interconnection between early and late signaling." Cells, 11(6), 953.
  • Wang Z., Li Z., Bal G., Franke K., Zuberbier T., & Babina M. (2022). "β-arrestin-1 and β-arrestin-2 Restrain MRGPRX2-Triggered Degranulation and ERK1/2 Activation in Human Skin Mast Cells." Frontiers in Allergy, 3. doi:10.3389/falgy.2022.930233
  • Wiebe E., Huscher D., Schaumburg D., Palmowski A., Hermann S., Buttgereit T., Biesen R., Burmester G.-R., Palmowski Y., & Boers M. (2022). "Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease." Annals of the Rheumatic Diseases, 81(9), 1313-1322.
  • Wiebe E., Huscher D., Schaumburg D., Palmowski A., Hermann S., Buttgereit T., Biesen R., Burmester G.-R., Palmowski Y., Boers M., Stone J. H., Dejaco C., & Buttgereit F. (2022). "Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease." Annals of the Rheumatic Diseases, 81(9), 1313-1322. doi:10.1136/annrheumdis-2022-222339

2021

  • Bonadonna P., Brockow K., Niedoszytko M., Elberink H. O., Akin C., Nedoszytko B., Butterfield J. H., Alvarez-Twose I., Sotlar K., & Schwaab J. (2021). "COVID-19 vaccination in mastocytosis: recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)." The Journal of Allergy and Clinical Immunology: In Practice, 9(6), 2139-2144.
  • Darlenski R., Kozyrskyj A. L., Fluhr J. W., & Caraballo L. (2021). "Association between barrier impairment and skin microbiota in atopic dermatitis from a global perspective: unmet needs and open questions." Journal of Allergy and Clinical Immunology, 148(6), 1387-1393.
  • Fluhr J. W., Gueguen A., Legoupil D., Brenaut E., Abasq C., Araújo H., & Misery L. (2021). "Teledermatology in times of COVID-19 confinement: comparing patients’ and physicians’ satisfaction by the standardized brest teledermatology questionnaire." Dermatology, 237(2), 191-196.
  • Hofmann M. A., Fluhr J. W., Ruwwe‐Glösenkamp C., Stevanovic K., Bergmann K. C., & Zuberbier T. (2021). "Role of IL‐17 in atopy—A systematic review." Clinical and Translational Allergy, 11(6), e12047.
  • Krause T., Bonnekoh H., Dilling A., Nast A., & Metz M. (2021). "A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report." JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 19, 1781-1783.
  • Krauss P.-L., Pfeiffenberger M., Damerau A., Buttgereit T., Chen Y., Gaber T., & Buttgereit F. (2021). "Production of IL-6 and phagocytosis are the most resilient immune functions in metabolically compromised human monocytes." Frontiers in Immunology, 12, 730672.
  • Legeas C., Misery L., ROUDOT A.-C., FICHEUX A.-S., & BRENAUT E. (2021). "Proposal for cut-off scores for sensitive skin on sensitive scale-10 in a group of adult women." Acta Dermato-Venereologica, 101(1).
  • Misery L., Brenaut E., Pierre O., Le Garrec R., Gouin O., Lebonvallet N., Abasq‐Thomas C., Talagas M., Le Gall‐ianotto C., & Besner‐Morin C. (2021). "Chronic itch: emerging treatments following new research concepts." British Journal of Pharmacology, 178(24), 4775-4791.
  • Misery L., Fluhr J.-W., Beylot-Barry M., Jouan N., Hamann P., Consoli S.-G., Schollhammer M., Charleux D., Bewley A., & Rathod D. (2021). Psychological and professional impact of COVID-19 lockdown on French dermatologists: Data from a large survey. Paper presented at the Annales de Dermatologie et de Venereologie.
  • Misery L., Morisset S., Séité S., Brenaut E., Ficheux A. S., Fluhr J., Delvigne V., & Taieb C. (2021). "Relationship between sensitive skin and sleep disorders, fatigue, dust, sweating, food, tobacco consumption or female hormonal changes: Results from a worldwide survey of 10 743 individuals." Journal of the European Academy of Dermatology and Venereology, 35(6), 1371-1376.
  • Muñoz M., Hegazy A. N., Brunner T. M., Holecska V., Marek R. M., Fröhlich A., & Löhning M. (2021). "Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10." Proceedings of the National Academy of Sciences, 118(6), e2002787118.
  • Pereira M. P., Zeidler C., Wallengren J., Halvorsen J. A., Weisshaar E., Garcovich S., Misery L., Brenaut E., Savk E., & Potekaev N. (2021). "Chronic nodular prurigo: a European cross-sectional study of patient perspectives on therapeutic goals and satisfaction." Acta Dermato-Venereologica, 101(2).
  • Pierre O., Fouchard M., Le Goux N., Buscaglia P., Leschiera R., Lewis R. J., Mignen O., Fluhr J. W., Misery L., & Le Garrec R. (2021). "Pacific-ciguatoxin-2 and brevetoxin-1 induce the sensitization of sensory receptors mediating pain and pruritus in sensory neurons." Marine Drugs, 19(7), 387.
  • Prado Acosta M., Goyette-Desjardins G., Scheffel J., Dudeck A., Ruland J., & Lepenies B. (2021). "S-Layer from Lactobacillus brevis modulates antigen-presenting cell functions via the Mincle-Syk-Card9 Axis." Frontiers in immunology, 12, 602067.
  • Werner R. N., Zidane M. T. C., Metz M., & Weyandt G. (2021). "Pruritus ani—Diagnostics and treatment: Recommendations from the updated German guidelines." coloproctology, 43, 97-105.
  • Wolf K., Kühn H., Boehm F., Gebhardt L., Glaudo M., Agelopoulos K., Ständer S., Ectors P., Zahn D., & Riedel Y. K. (2021). "A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice." Journal of Allergy and Clinical Immunology, 148(2), 506-522. e508.
  • Yanai K., Yoshikawa T., & Church M. K. (2021). "Efficacy and Safety of Non-brain Penetrating H1-Antihistamines for the Treatment of Allergic Diseases." The Functional Roles of Histamine Receptors, 193-214.

2020

  • Ständer S., Pereira M. P., Berger T., Zeidler C., Augustin M., Bobko S., Brenaut E., Chen S. C., Chisolm S., & Dalgard F. J. (2020). "IFSI-guideline on chronic prurigo including prurigo nodularis." Itch, 5(4), e42.